https://www.fiercebiotech.com/biotech/after-2020-flop-milestones-arrhythmia-nasal-spray-hits-phase-3
After 2020 flop, Milestone's arrhythmia spray hits in phase 3
Oct 17, 2022 - Thirty months after failing its first phase 3, the nasal spray treatment for abnormal heart rhythm has beaten placebo in a second study.
milestone sin phase2020flop
https://store.steampowered.com/publisher/Milestone?snr=1_5_9__2000
Steam Publisher: Milestone S.r.l.
milestone ssteampublisher